Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) is dated May 29, 2026, with a signature date of June 1, 2026. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards on the Nasdaq Capital Market.
Key Financial Metrics
- Stockholders' Equity: $814,038 (as reported in the Form 10-Q for the period ended March 31, 2026).
- Nasdaq Minimum Equity Requirement: $2,500,000.
- Compliance Status: The company does not meet the minimum stockholders' equity standard, nor does it meet the alternative standards for market value of listed securities or net income.
- Revenue, Profit, Cash Flow, Debt, and Liquidity: The filing text does not provide specific values for these metrics beyond the stockholders' equity figure.
Material Changes and Events
On May 29, 2026, the company received a formal Notice from Nasdaq stating it no longer complies with Listing Rule 5550(b)(1) due to insufficient stockholders' equity. This represents a material deviation from the required financial thresholds for continued listing. The notice has no immediate effect on the trading of the company's common stock, which continues to trade under the symbol "ISPC."
Outlook, Management Commentary, and Risks
- Compliance Plan: The company intends to submit a plan to regain compliance within the required 45-day window following the notice.
- Timeline: If a plan is accepted, the company may receive an extension of up to 180 calendar days to demonstrate compliance.
- Risks and Contingencies: There is no assurance that Nasdaq will accept the proposed plan or that the company will regain compliance within the allotted time. If the plan is rejected, the company retains the right to appeal the decision to a Nasdaq Hearings Panel.
- Delisting Risk: Failure to regain compliance could result in the delisting of the company's common stock.
Investor Verification Checklist
- Verify the current stockholders' equity balance as of the most recent financial statement to confirm the $814,038 figure.
- Monitor the company's submission of a compliance plan to Nasdaq within the 45-day deadline.
- Review the company's Form 10-Q for the period ended March 31, 2026, for detailed financial context regarding the equity shortfall.
- Track any subsequent announcements regarding Nasdaq's acceptance or rejection of the compliance plan.